Verla-Pharm Arzneimittel GmbH & Co KG und Xenofit GmbH Sustainability Reports
Verla-Pharm Arzneimittel GmbH & Co. KG develops, manufactures, and distributes pharmaceuticals and dietary supplements, specializing as a market leader in mineral therapy and magnesium preparations. Its subsidiary Xenofit GmbH provides a matching portfolio of sports nutrition products.
Sector: Manufacturing
Country: Germany
Exchange: Unlisted
LEI: 529900XSAPCANMNAJF98
1 reports from 2021 to 2021